FDA Issues Statement on IV Fluid Shortage
Agency is working with manufacturers to fix the problem (January 17)
In an online statement posted Jan. 17, the FDA said that it is aware of the shortage situation for intravenous (IV) solutions, particularly 0.9% sodium chloride injection (i.e., saline), used to provide patients with the necessary fluids for hydration and other conditions.
The shortage has been triggered by a range of factors, including a potential increase in use by hospitals, potentially related to the flu season, the agency says.
The FDA is working with the three manufacturers of IV solutions — Baxter Healthcare Corp., B. Braun Medical Inc., and Hospira Inc. — to help preserve the supply of these products. Addressing the shortage will depend, however, on the increased demand and on the manufacturing production of the current suppliers.
Millions of IV solutions are used each week by health care professionals.
Source: FDA; January 17, 2014.